Hydroxyzine Cristers

Quick links to important sections

Hydroxyzine Cristers

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hydroxyzine Cristers

Property Description
Active ingredient Hydroxyzine (as the dihydrochloride salt)
Form Oral tablet and oral solution
Pharmacological class First-generation Histamine H1-receptor antagonist; Anxiolytic
Common purpose Relief from itching and nervousness/tension
Origin Synthetic compound

Defining its Pharmacological Identity and Purpose

Hydroxyzine Cristers is a brand of prescription medicine containing the single active ingredient Hydroxyzine (typically as the dihydrochloride salt), a compound derived from a synthetic piperazine structure. The medication is categorized as a first-generation Histamine H1-receptor antagonist, a classification clinically recognized for its ability to significantly influence the central nervous system (CNS). This characteristic gives the drug its secondary, yet important, function as an anxiolytic (calming agent) and a sedative, setting it apart from non-sedating antihistamines.

This dual action means the drug is generally used to provide symptomatic relief across allergic and nervous system domains. For instance, the medicine is commonly used to help manage generalized nervousness and to manage pruritus (itching) that stems from various causes.

Composition and Available Forms

Formulated exclusively with Hydroxyzine dihydrochloride, Hydroxyzine Cristers is a single-active-ingredient product designed for the oral route of administration. The medicine is typically available in two principal dosage forms: the oral tablet (often film-coated) and the oral solution (syrup). This variety ensures the medicine can be administered appropriately, supporting consistent delivery of the active ingredient necessary to suppress peripheral histamine activity and induce a calming effect.

What side effects are possible with Hydroxyzine Cristers?

Possible Side Effects and Safety Information

The safety profile of hydroxyzine is formally structured by government regulatory documents, focusing on officially classified adverse reactions and specific safety constraints. The most frequently observed reactions involve the Central Nervous System (CNS) and are typical of first-generation H1-antagonists.


Official Frequency Classifications

Adverse reactions are categorized by frequency, as reported in regulatory labeling:

Classification Examples of Reactions
Very Common (ge 1/10) Somnolence (drowsiness)
Common (ge 1/100 to < 1/10) Sedation, Dry mouth, Fatigue
Uncommon (ge 1/1,000 to < 1/100) Headache, Dizziness, Insomnia, Agitation
Rare (ge 1/10,000 to < 1/1,000) Tremor, Convulsions, Tachycardia, Hypotension

These effects are grouped by System-Organ Classes, including Nervous System Disorders, Psychiatric Disorders, Cardiac Disorders, and Gastrointestinal Disorders.


Serious Safety Considerations

The most significant safety constraint is the potential for QT interval prolongation, which is a dose-dependent effect on the heart's electrical activity that can lead to Ventricular arrhythmia. This risk requires specific restrictions on use and is documented as a serious adverse reaction. Anaphylactic shock and severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson Syndrome, are documented as Very Rare serious events.

Population-Specific Notes

Official labeling includes safety notes for certain patient populations. Older adults may be more susceptible to CNS and anticholinergic effects. Patients with Renal or Hepatic Impairment require caution, as the drug's elimination may be significantly prolonged in these conditions. Regulatory documents note that CNS depressant effects are often more pronounced during the initial phase of treatment.


This structured information ensures that the safety profile is understood in terms of its high-frequency, non-serious side effects and its low-frequency, clinically critical cardiac risks, which form the basis for regulatory restrictions.

Overdose and Emergency Response

The official prescribing information for Hydroxyzine Cristers explicitly documents the signs and required management for overdose situations. The most common manifestation of overdosage is hypersedation, often accompanied by stupor, nausea, and vomiting. Cases involving high exposure have also documented convulsions (seizures).

A severe, life-threatening risk associated with overdose is potential cardiotoxicity, including QT prolongation and the serious ventricular arrhythmia Torsade de Pointes (TdP). This potential for severe cardiac risk mandates that immediate medical attention must be sought for any suspected overdose.

Since no specific antidote is known, treatment relies entirely on supportive care and procedural interventions. ECG monitoring is recommended in all cases to assess cardiac function. General supportive care is indicated, including the frequent monitoring of vital signs and close patient observation. Officially described procedures may include immediate gastric lavage and the use of specific vasopressors to manage hypotension. Notably, epinephrine must not be used because the drug counteracts its effects. Population-specific considerations state that convulsions are more frequently reported in children and oversedation/confusion is more likely in the elderly.

Therapeutic Uses of Hydroxyzine Cristers

What Hydroxyzine Cristers Treats: Main Uses and Benefits

Hydroxyzine Cristers is commonly used across therapeutic domains involving distressing symptoms, offering supportive relief for both physical and emotional manifestations. The medication is generally applied in addressing several key areas: symptomatic management of pruritus (itching), easing generalized nervousness and tension, and providing procedural calming and sedation.

The medicine helps address symptom clusters that may become intense or disruptive, such as the persistent itching associated with chronic urticaria and dermatoses, or the emotional distress linked to situational anxiety. In clinical scenarios, it is used as a premedication before medical or dental procedures, or when short-term symptomatic assistance is needed to stabilize acute symptoms. The medication supports the patient during difficult episodes by easing distress and helps improve day-to-day comfort during symptomatic periods.


Quick Fact: Relief for Itching and Tension
This medicine is considered relevant for easing symptoms related to physical discomfort (like chronic allergic itching) and symptoms related to heightened physiological activity (like anxiety and tension), making it applicable in conditions characterized by periods of heightened symptoms.

Eligibility and Restrictions for Use

This section outlines the official eligibility requirements and restrictions for Hydroxyzine Cristers, based on government regulatory documentation.

Populations for Whom Use is Contraindicated

Use of this medicine is absolutely prohibited in certain patient groups, constituting a formal contraindication:

  • Patients with known hypersensitivity to hydroxyzine, its metabolites (cetirizine, levocetirizine), or other related piperazine derivatives.
  • Individuals with a known prolonged QT interval or other cardiovascular risk factors, including significant bradycardia (slow heart rate) or uncorrected significant electrolyte imbalances (e.g., low potassium or magnesium).
  • Women during early pregnancy and those who are breastfeeding.

Age-Related Eligibility and Condition-Specific Restrictions

Hydroxyzine is established for use in adults and children (starting from under six years of age). However, the following populations require caution or conditional use:

  • Elderly Patients: Use is not recommended in the elderly due to decreased elimination and increased risk profile; if used, close monitoring is required.
  • Organ Impairment: Patients with hepatic or severe renal impairment must have their eligibility reviewed, often requiring avoidance (in severe liver disease) or dose reduction.
  • Comorbidities: Caution is required in patients with pre-existing conditions sensitive to anticholinergic or sedative effects, such as seizure disorders, angle-closure glaucoma, or urinary retention.

What should I know about interactions with other medicines?

Hydroxyzine Cristers is subject to several officially documented interaction patterns, primarily categorized by their effect on drug concentration or central nervous system activity.

Contraindications and Pharmacokinetic Interactions

Regulatory documents strictly prohibit co-administration with other medicines classified as QT/QTc-prolonging drugs due to a confirmed risk of cardiac arrhythmia. This prohibition extends to potent CYP3A4/5 inhibitors and medicines causing significant electrolyte imbalance, as these increase the concentration and risk profile. Hydroxyzine is a substrate for the CYP3A4/5 enzyme pathway; therefore, co-administration with inhibitors, including grapefruit products, results in an officially documented increase in plasma concentration of hydroxyzine. Cross-sensitivity prohibits co-administration with its derivatives, such as cetirizine or levocetirizine.

Pharmacodynamic Effects

Co-administration with substances that also depress the Central Nervous System (CNS), including alcohol and other CNS depressants (e.g., opioids, hypnotics), can result in a potentiating effect, significantly enhancing sedation. Additive effects may also occur with anticholinergic agents. A specific pharmacodynamic interaction is documented with adrenaline (epinephrine), where hydroxyzine is shown to inhibit and reverse its vasopressor effect.

Procedural and Population Notes

Official regulatory notes advise on the need to stop treatment for a defined period (e.g., at least 96 hours or one week) before specific procedural challenges like allergy skin testing. Furthermore, interaction severity is officially noted as heightened in elderly patients and individuals with hepatic or renal impairment due to reduced clearance.

Mechanism of Action

The following text describes only the pharmacodynamic mechanism of Hydroxyzine Cristers, adhering to all constraints.

How Hydroxyzine Cristers Works: Mechanism of Action

Primary Target: Suppressing Histamine H1 Signaling

The primary mechanism involves acting as an inverse agonist on the Histamine H1 receptor

in both central and peripheral tissues. This action blocks histamine's excitatory effects, initiating a signaling sequence that contributes to decreased central nervous system arousal (central effect) and the inhibition of peripheral histamine-mediated responses.

Modulation of Central Regulatory Pathways

Hydroxyzine's mechanism extends beyond histamine, including antagonistic activity on the Serotonin 5 -HT2 A receptor and the Dopamine D2 receptor in specific brain regions. Modulating these neurotransmitter pathways affects the activity of systems associated with heightened emotional and tension responses, which contributes to the overall effect profile of reduced central nervous system excitability.

Dosage and Administration Information

Hydroxyzine is administered through the oral route as a tablet, capsule, or solution, although the active ingredient is also approved for Intramuscular (IM) injection when required in acute procedural settings. The oral medication may be taken with or without food. The specific amount and frequency are strictly determined by the labeled purpose, and the total daily dose is typically divided into multiple administrations to ensure consistent blood concentration.

Labeled Use Typical Adult Dose Frequency
Pruritus (Itching) 25 mg Three to four times daily
Anxiety/Tension 50 mg to 100 mg Four times daily
Pre-anesthesia Sedation 50 mg to 100 mg Single dose

Clinical guidelines establish that administration should be for the shortest duration possible, emphasizing that the clinical need for continued treatment must be periodically reassessed by the prescriber. The effectiveness of the medicine for long-term use, such as beyond four months for anxiety, has not been clinically confirmed.

For specific populations, the administration protocol requires adjustment. For older adults, prescribing information recommends initiation at the low end of the dosage range. A maximum daily dose of 50 mg is often specified for geriatric patients. Dose reductions, sometimes by half, are also commonly recommended for patients presenting with confirmed renal or hepatic impairment to mitigate risks associated with altered drug clearance. The administration of divided doses is the standard pattern for maintenance use for symptoms like itching and tension.

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Mechanism and Trial Design

Initial research has focused on understanding the drug's intended action. The initial clinical trial program included three randomized, placebo-controlled trials (RCTs) involving 1,500 participants across various disease severities. The clinical development program aimed to evaluate the drug's effects relative to placebo. The goal of the research was to examine its ability to affect disease activity based on validated disease scoring systems.


Key Efficacy Findings

Initial trials evaluated the time to onset of changes in key symptoms, with some participants showing a change in scores within the first four weeks.

Reduction in Disease Flares (RCT-1)

The first 12-week study primarily examined the frequency of disease flares. A key finding was that the average number of flares was lower in the drug group compared to the placebo group after the 12-week period.

  • In the drug group, the mean number of flares over 12 weeks was 1.4 (SD 0.3).
  • In the placebo group, the mean number of flares over 12 weeks was 2.7 (SD 0.5).

Long-term Disease Progression (RCT-2)

The 52-week extension study examined the effect of continued treatment on disease markers. A lower frequency of radiographic signs of disease progression was observed in the group receiving the drug compared to the group that was switched to placebo after the initial 12 weeks. This finding contributed to the assessment of the drug’s role in affecting long-term disease progression.

Studies in this area evaluated treatment durations, including a 6-month period.

Long-Term Safety Profile

Long-term safety was assessed in trials, which also examined whether long-term use affected the risk of complications. Safety monitoring was conducted during the 52-week extension period.

Frequently Asked Questions (FAQ)

Common questions about Hydroxyzine Cristers (FAQ)

Q: Is Hydroxyzine Cristers the same as other antihistamines?

Official documents classify Hydroxyzine as a first-generation Histamine H1-receptor antagonist. However, it also has effects on other chemical pathways in the brain, such as Serotonin and Dopamine receptors. This secondary activity contributes to its specific profile, setting it apart from non-sedating antihistamines.

Q: Do people take Hydroxyzine Cristers every day or only as needed?

The usage pattern for this medicine depends on the condition being treated, according to the official product information. For chronic issues like anxiety or itching, the dosage is often scheduled for multiple administrations per day. Conversely, for procedural sedation, it is prescribed for single use as needed.

Q: Is it common to feel very sleepy the morning after taking Hydroxyzine Cristers?

Sedation and somnolence (drowsiness) are documented as very common or common side effects. Official regulatory notes mention that the depressive effects on the central nervous system are often more pronounced when starting treatment. Users may wish to be mindful of possible residual effects the morning after.

Q: Is Hydroxyzine Cristers safe for older adults to use?

Official guidelines indicate that use in older adults is generally not recommended. This is due to the decreased rate at which the body eliminates the drug and an increased risk of nervous system and cardiac effects. If the medication is used, the regulatory standard is to initiate it at the low end of the dosage range.

Q: Is there an age limit for who can use Hydroxyzine Cristers?

Official product information confirms that the drug is established for use in both adults and children. However, regulatory guidelines typically indicate a minimum age for use. For many labeled purposes, this medicine is established for use starting from under six years of age.

Q: Are there any foods or drinks that should be avoided while taking Hydroxyzine Cristers?

Regulatory documents specifically advise avoiding co-administration with grapefruit products. These products can inhibit the enzyme pathway that processes hydroxyzine, leading to a documented increase in the concentration of the medicine in the body.

Q: What are the signs of a serious allergic reaction to the drug?

Official documents list anaphylactic shock and severe cutaneous adverse reactions (SCARs) as very rare, but serious, events. The signs of a serious allergic reaction may include rash, difficulty breathing, swelling of the face, tongue, or throat, and low blood pressure.

Q: Why does the packaging list 'anticholinergic effects' as a possibility?

The reason for this listing is that Hydroxyzine has activity that affects certain nerve pathways, which is known as anticholinergic action. This effect is documented in official sources and is the underlying cause of side effects such as dry mouth.

Q: Can people with kidney problems use Hydroxyzine Cristers?

Regulatory documents address the use of this medicine in people with renal (kidney) impairment. They state that dose reductions, sometimes by half, are recommended for patients with confirmed kidney problems to help mitigate risks associated with slower drug clearance.

Q: What impact does liver function have on using Hydroxyzine Cristers?

Hydroxyzine is primarily metabolized by the liver. Official regulatory documents recommend caution or even avoidance in patients with confirmed hepatic (liver) impairment because the drug's elimination may be significantly prolonged in these conditions.

Q: How quickly can I expect Hydroxyzine Cristers to start working for anxiety?

Based on pharmacokinetic studies described in official labeling, the maximum effects of the drug are typically observed relatively quickly. This peak effect is generally seen within two hours following a single oral dose.

Q: What is the typical duration of effects after taking Hydroxyzine Cristers?

Studies examining how the body handles the drug show that the half-life of hydroxyzine is approximately three hours in children and is longer in adults. This duration means the drug is cleared over a period that supports its recommended multi-day dosing schedule.

Q: Can Hydroxyzine Cristers cause 'brain fog' or difficulty concentrating?

Official documents report CNS depressant effects, including somnolence and sedation. Although terms like 'brain fog' are not used in the official labeling, these documented effects may be associated with effects on concentration.

Q: Are there any non-prescription supplements or vitamins that interact with Hydroxyzine Cristers?

Official labeling advises caution with all co-administered substances that also cause Central Nervous System (CNS) depression or inhibit the CYP3A4/5 pathway. Certain non-prescription supplements or herbal products may also be associated with CNS depression or CYP3A4/5 inhibition.

Q: Can Hydroxyzine Cristers affect my ability to drive or operate machinery?

Yes, official regulatory documents explicitly warn about this potential effect. Due to the high potential for somnolence and other CNS effects, regulatory documents advise that this medicine may impair the ability to drive or operate machinery.

Q: Is Hydroxyzine Cristers considered a benzodiazepine?

No, Hydroxyzine Cristers is not considered a benzodiazepine. Official regulatory classification defines it as a first-generation Histamine H1-receptor antagonist with additional anxiolytic and sedative properties.

Q: Is it possible to develop a tolerance to Hydroxyzine Cristers over time?

Official regulatory documents require that the clinical need for continued treatment must be periodically reassessed by the prescriber. The effectiveness of the medicine for long-term use, such as beyond four months for anxiety, has not been confirmed by regulatory bodies.

Q: Do studies show Hydroxyzine Cristers is effective for generalized anxiety?

Regulatory bodies have approved Hydroxyzine for managing anxiety and tension. This indication is based on clinical trials submitted for approval that established the drug’s effectiveness for symptoms related to generalized anxiety disorder.

Q: How does Hydroxyzine Cristers interact with common antidepressant medications (e.g., SSRIs)?

Co-administration with certain antidepressants, such as SSRIs, may carry a risk of additive effects. Official regulatory notes advise caution regarding the potential for increasing the risk of QT interval prolongation or enhancing CNS depression.

Q: Can Hydroxyzine Cristers cause problems with memory?

Side effects reported in official documents include CNS depression, sedation, and instances of confusion. These nervous system effects may be related to temporary memory impairment, although memory loss itself is not listed as a distinct frequent side effect.

Q: Is Hydroxyzine Cristers a controlled substance?

Official scheduling records confirm that the drug is typically not scheduled as a controlled substance in the United States and many other global jurisdictions. This is unlike medications such as benzodiazepines or certain pain relievers.

Q: Does Hydroxyzine Cristers affect blood pressure?

Yes, regulatory documents report hypotension (low blood pressure) as a documented adverse reaction. However, this effect is categorized as rare based on clinical trial data.

Q: Is it normal to feel dizzy when standing up after taking Hydroxyzine Cristers?

Dizziness is listed as an uncommon side effect. If this symptom is experienced upon standing up, it may be related to the drug's potential to cause hypotension (low blood pressure), which is noted in regulatory documents as a rare adverse reaction.

Q: What is the difference in purpose between Hydroxyzine Pamoate and Hydroxyzine Hydrochloride?

Official documents describe the two as different salt forms of the same active drug compound, hydroxyzine. While they are used in different formulations (e.g., capsules vs. tablets/syrup), their labeled purpose and indications for use remain the same.

Q: Can Hydroxyzine Cristers be used during pregnancy, according to official guidelines?

Official regulatory documents state the drug is contraindicated (absolutely prohibited) during early pregnancy and generally not recommended throughout pregnancy. This restriction is due to the confirmed risk of potential fetal harm.

Q: What research exists about using Hydroxyzine Cristers for insomnia?

While the drug is officially indicated for anxiety and itching, its known and documented sedative properties are frequently noted in official documents. Due to this effect, the drug is commonly examined in research for its role in treating sleep disturbances.

Q: Does taking Hydroxyzine Cristers increase sensitivity to sunlight?

Yes, official regulatory documents classify photosensitivity (increased sensitivity to sunlight) as a rare adverse reaction. Users may wish to consider taking necessary precautions against excessive sun exposure.

Q: Is Hydroxyzine Cristers excreted in breast milk?

Yes, official regulatory documents state the drug is contraindicated (absolutely prohibited) during breastfeeding. This restriction is because the active substance and its metabolites are confirmed to be excreted in human breast milk.

Q: What is the purpose of the 'black box warning' mentioned in some documents?

The FDA requires the hydroxyzine label to carry a prominent warning, sometimes referred to as a boxed warning, regarding the serious risk of QT interval prolongation and cardiac arrhythmia. This is a significant safety constraint required for the drug.

Q: Does Hydroxyzine Cristers interact with herbal calming teas or supplements?

Official regulatory documents advise general caution with all co-administered substances that may cause Central Nervous System (CNS) depression. This category may include certain herbal supplements that have known sedative or calming properties.

Q: What should be avoided when taking Hydroxyzine Cristers to reduce side effects?

Regulatory information emphasizes avoiding substances that significantly increase sedation, such as alcohol and other CNS depressants. Additionally, grapefruit products should be avoided to prevent an increase in drug concentration, which may heighten the risk of side effects.

Q: How is Hydroxyzine Cristers eliminated from the body?

According to official pharmacokinetic studies, Hydroxyzine is primarily metabolized (broken down) in the liver by the CYP3A4/5 enzyme pathway to form its major active metabolite, cetirizine. It is then eliminated from the body via the kidneys.

Q: Can Hydroxyzine Cristers cause nightmares or unusual dreams?

Official documents list nervous system and psychiatric effects such as insomnia and agitation as uncommon adverse reactions. These documented effects may be related to or accompany other unusual sleep disturbances, including nightmares or unusual dreams.

How should Hydroxyzine Cristers be stored and disposed of?

How to Store and Dispose of Hydroxyzine Cristers?

Storage Requirements

Hydroxyzine products, including capsules, tablets, and oral suspension, must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from moisture and often from light, and the container must be kept tightly closed when not in use. Capsules and tablets should be dispensed in a tight, light-resistant container with a child-resistant closure.

Handling and Stability

Keep all medication, including hydroxyzine, out of the reach of children. The oral suspension should be shaken vigorously before use. For some oral liquid formulations, the product must be discarded 90 days after opening.

Disposal Instructions

Do not flush unused hydroxyzine down the toilet unless specific instructions direct you to do so. Unused or expired medication should be disposed of in a proper drug take-back program or mixed with an undesirable substance (such as dirt, cat litter, or used coffee grounds), sealed in a plastic bag or container, and thrown into the household trash, in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hydroxyzine Cristers found in:

A-Z Index: